e-ISSN: Pending
Negative / Null Result ReportOpen accessMedicine· cited by 15

Serum Uric Acid Level as a Biomarker in Idiopathic and Genetic (p.A53T Alpha-Synuclein Carriers) Parkinson’s Disease: Data from the PPMI Study

Christos Koros; Athina‐Maria Simitsi; Dimitra Papadimitriou; Anastasia Bougea; Andreas Prentakis; Nikolaos Papagiannakis; Ioanna Pachi; Maria Bozi · 2020 · Journal of Parkinson s Disease

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

BACKGROUND: Blood uric acid level represents an emerging biomarker in Parkinson's disease (PD). Whether uric acid levels change in genetic forms of PD is just beginning to be explored. OBJECTIVE: The aim of the present study was to assess differences in serum uric acid level among PD patients harboring the p.A53T mutation in the alpha-synuclein gene, idiopathic PD, and healthy controls. METHODS: Longitudinal 5-year serum uric acid measurement data of 369 de novo idiopathic PD patients and 174 age- and gender-matched healthy controls have been downloaded from the Parkinson's Progression Markers

Abstract by Christos Koros; Athina‐Maria Simitsi; Dimitra Papadimitriou; Anastasia Bougea; Andreas Prentakis; Nikolaos Papagiannakis; Ioanna Pachi; Maria Bozi, Journal of Parkinson s Disease (2020) — licensed CC BY-SA 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.3233/jpd-191860